HJF has named Dr. Merlin Robb as its Chief Medical Advisor. Robb brings more than 30 years of medical research experience to the role.

<p>HJF was named one of the 2019 Best Place to Work in the Washington Area by the Washington Business Journal.&nbsp;</p>

Dr. Joseph Caravalho, Jr. spoke at the 2019 Gonzaga University commencement ceremony. Dr. Caravalho is an alum of Gonzaga University, class of 1979.

Mr. Kelly McKeague is an accomplished leader and was the keynote speaker for HJF’s 9th Annual Heroes of Military Medicine Awards.

On May 9, 2019 top researchers and practitioners of military medicine will come together to honor the 2019 Heroes of Military Medicine.

HJF prides itself on being careful stewards of the resources it uses, especially those celebrated on Earth Day!

HJF, along with Uniformed Services University were awarded up to $24.5 million to advance treatments for two lethal henipaviruses.

HJF has teamed with Tracy's Kids to help provide pediatric art therapy to cancer patients at a military treatment facility

Developing Vaccines and Therapies for the Highly Pathogenic Nipah and Hendra Viruses with HJF and multiple partners.

Tom Weston, SVP and CFO of ECS Federal, LLC. has joined HJF's Council of Directors.

HJF has entered into a cooperative agreement with the Defense POW/MIA Accounting Agency.

HJF has selected Uniformed Services University doctoral student to receive a fellowship for the 2018-19 academic year.

HJF has facilitated the transfer of the m102.4 antibody, an experimental therapy for Nipah virus infection, from Queensland, Australia to Kerala, India.

HJF President and CEO Joseph Caravalho, Jr., M.D., recently served as a panelist during the “Science and Synergy” Spring Research Summit.

HJF has announced a license agreement of the vaccine for Nipah virus and Hendra virus.